What pharma marketing can learn from defense-grade data strategy (and why it matters now)

In a fragmented, privacy-constrained environment, healthcare marketers are under pressure to prove that their audiences are accurate and defensible. This article examines why many segments fall short and how a cohort-based, data-first approach can improve targeting, measurement and campaign performance.